JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
There are no items in your shopping cart
Featured Products
Axon 4149
CAS [159351-69-6]
MF C53H83NO14MW 958.22
Everolimus is a Rapamycin derivative. It is currently used as an immunosuppressant to prevent rejection of organ transplants and as an mTOR inhibitor to treat renal cell cancer and other tumors.
Keywords: Everolimus | Supplier | mTOR1 inhibitor | RAD001 | RAD-001 | RAD 001 | CT-EVER | CAS [159351-69-6] | Phosphatidylinositol | mTOR | Inhibitor | Enzymes
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,2
[159351-69-6]
The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.
Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!
* Required Fields